Tapewire

Nasdaq · USD

CERS

CERUS CORP

Export transactions ↓
Tapewire entity
5431
SEC CIK
0001020214
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 2026015
Apr 202600
May 202602
Jun 202605
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · derivative · entry 5

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
Exercise / conversionCommon Stock 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 3

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
Exercise / conversionCommon Stock 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 1

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 64,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · derivative · entry 6

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,666

Underlying: Common Stock · 64,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 107,525 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · derivative · entry 5

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 107,525 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
Exercise / conversionCommon Stock 64,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 3

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,681,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
Exercise / conversionCommon Stock 107,525 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 1

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,654,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 21,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · derivative · entry 6

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,666

Underlying: Common Stock · 21,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · derivative · entry 5

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionCommon Stock 21,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 3

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionCommon Stock 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 1

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 6

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 5

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionCommon Stock 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 3

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,267,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionCommon Stock 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 1

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,260,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · derivative · entry 7

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F6 · price: Not applicable.

F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · derivative · entry 6

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F6 · price: Not applicable.

F5 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F5 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 3

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:24 UTC
Moore CarolSVP Reg. & Quality
GrantRestricted Stock Unit 110,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015792 · doc4.xml · nonDerivative · entry 1

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,866

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 4,598 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:21 UTC
Jensen ChrystalChief Legal Officer
GrantRestricted Stock Unit 160,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015783 · doc4.xml · nonDerivative · entry 1

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,871

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:19 UTC
Jayaraman Vivek KChief Operating Officer
GrantRestricted Stock Unit 240,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015772 · doc4.xml · nonDerivative · entry 1

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 614,226

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 4,812 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:17 UTC
Greenman William MarinerDirector · President and CEO
GrantRestricted Stock Unit 575,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015762 · doc4.xml · nonDerivative · entry 1

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,546,634

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 4,442 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:16 UTC
Green Kevin DennisChief Financial Officer
GrantRestricted Stock Unit 185,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015758 · doc4.xml · nonDerivative · entry 1

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,999

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:14 UTC
CORASH LAURENCE MChief Scientific Officer
GrantRestricted Stock Unit 110,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015748 · doc4.xml · nonDerivative · entry 1

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,236,716

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:13 UTC
Benjamin Richard JChief Medical Officer
GrantRestricted Stock Unit 160,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015736 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,665

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
December 28, 2022 Filed Jan 3, 2023 23:40 UTC Amendment
SCHULZE GAILDirector
Exercise / conversionOption (Right to Buy) · Derivative 25,000 Not disclosed Strike: $3.19 Not disclosed
Disclosure

SEC source: 0001209191-23-000425 · doc4a.xml · derivative · entry 2

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date.

Read SEC document
December 28, 2022 Filed Jan 3, 2023 23:40 UTC Amendment
SCHULZE GAILDirector
Exercise / conversionCommon Stock 25,000 $3.19 $79,750.00
Disclosure

SEC source: 0001209191-23-000425 · doc4a.xml · nonDerivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:25 UTC Exercise / conversionOption (Right to Buy) · Derivative 12,500 Not disclosed Strike: $3.19 Not disclosed
Disclosure

SEC source: 0001209191-22-056776 · doc4.xml · derivative · entry 3

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:25 UTC SaleCommon Stock 12,500 $3.91 $48,875.00
Disclosure

SEC source: 0001209191-22-056776 · doc4.xml · nonDerivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,808

F1 · price: The sales occurred in multiple trades at prices ranging from $3.915 to $3.910. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:25 UTC Exercise / conversionCommon Stock 12,500 $3.19 $39,875.00
Disclosure

SEC source: 0001209191-22-056776 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 21:11 UTC
Jensen ChrystalChief Legal Officer
SaleCommon Stock 10,000 $5.18 $51,800.00
Disclosure

SEC source: 0001209191-22-046374 · doc4.xml · nonDerivative · entry 1

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,871

F1 · price: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 23:05 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 10,000 $5.12 $51,194.00
Disclosure

SEC source: 0001209191-22-045495 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,665

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:47 UTC
Shan HuaDirector
GrantOption (Right to Buy) · Derivative 58,074 Not disclosed Strike: $5.48 Not disclosed
Disclosure

SEC source: 0001209191-22-041941 · doc4.xml · derivative · entry 2

Shan Hua · CIK 0001937467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,074

Underlying: Common Stock · 58,074 shares

Expires 2032-06-30

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option grant vests in three equal annual installments beginning on anniversary of the transaction date.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:47 UTC
Shan HuaDirector
GrantCommon Stock 29,886 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-041941 · doc4.xml · nonDerivative · entry 1

Shan Hua · CIK 0001937467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,886

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on anniversary of the transaction date, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:22 UTC
Witney FrankDirector
GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034214 · doc4.xml · derivative · entry 2

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:22 UTC
Witney FrankDirector
GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034214 · doc4.xml · nonDerivative · entry 1

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,059

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:19 UTC GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034210 · doc4.xml · derivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:19 UTC GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034210 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,808

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:17 UTC
SCHULZE GAILDirector
GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034209 · doc4.xml · derivative · entry 2

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:17 UTC
SCHULZE GAILDirector
GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034209 · doc4.xml · nonDerivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,570

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:14 UTC GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034207 · doc4.xml · derivative · entry 2

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:14 UTC GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034207 · doc4.xml · nonDerivative · entry 1

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,362

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:12 UTC GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034204 · doc4.xml · derivative · entry 2

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:12 UTC GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034204 · doc4.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,073

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:08 UTC GrantOption (Right to Buy) · Derivative 39,866 Not disclosed Strike: $4.84 Not disclosed
Disclosure

SEC source: 0001209191-22-034203 · doc4.xml · derivative · entry 2

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,866

Underlying: Common Stock · 39,866 shares

Expires 2032-05-31

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option shall vest one year from the date of grant.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:08 UTC GrantCommon Stock 20,454 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034203 · doc4.xml · nonDerivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,133

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
May 10, 2022 Filed May 12, 2022 22:36 UTC
Green Kevin DennisChief Financial Officer
SaleCommon Stock 57,335 $4.98 $285,373.50
Disclosure

SEC source: 0001209191-22-028638 · doc4.xml · nonDerivative · entry 1

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,999

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.77 to $5.28 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 02:00 UTC
Greenman William MarinerDirector · President and CEO
SaleCommon Stock 33,276 $5.04 $167,697.73
Disclosure

SEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 6

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,967,192

F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 02:00 UTC
Greenman William MarinerDirector · President and CEO
SaleCommon Stock 53,702 $5.04 $270,631.23
Disclosure

SEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 4

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,935,801

F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.